gip/glp-1 receptor agonist drugs GLP-1/GIP Agonists and Diabetic Retinopathy: What ODs Should Know GLP‑1 Receptor Agonists and Preclinical

While most health plans do not currently cover obesity medications like Wegovy and Zepbound and MedBen Rx recommends clients continue not to do so constant media coverage means the calls to do so will only grow

Approved 20 years ago as a treatment for diabetes, GLP-1 drugs have been found also to help patients significantly reduce weight

The reason why may be genetics

Exposures Two cohorts were assembled, with the first composed of patients who started and continued on GLP-1 receptor agonists or DPP-4 inhibitors between 1 January 2007 and 31 December 2020 and the second composed of patients who started and continued on GLP-1 receptor agonists or SGLT-2 inhibitors between 1 January 1 2013 and 31 December 2020

Here, we provide a comprehensive review of the therapeutic potential of incretin mimetics and insulin in AD and PD.